Addressing Coronavirus in African Countries With High HIV Rates: An Interview With UNAIDS Head Winnie Byanyima
Byanyima discusses COVID-19, HIV, and the power of the community response.
Retire? No, Thanks! This Doc Instead Moved to West Virginia to Fight HIV, Hepatitis C, and the Opioid Crisis
In a poor and conservative state, Judith Feinberg, M.D., aims to expand harm reduction—and bring treatment to active drug users.
As With HIV, New York State Was Set to Lead the Nation to End Hepatitis C. But Why Haven’t the Recommendations Been Made Public?
Activist and member of the state task force Annette Gaudino would like the public to know.
The HIV services organization Housing Works implemented a hepatitis C treatment program in New York City, with very high completion rates.
Steven Deeks, M.D., talks about the medical community's hopes, inspirations, and unanswered questions regarding research for an HIV cure.
Distal sensory polyneuropathy affects approximately 50% of persons living with HIV. We spoke with neuroscience mentor and mentee to discuss how to reduce the risk of neuropathy and what treatments are available.
International AIDS Conference Day 5: Dr. Valdiserri Talks to Dr. John Brooks About HIV and Flu -- A Blog Entry From Positive Policy
This article was cross-posted from the AIDS.gov blog. Dr. Ron Valdiserri is Deputy Assistant Secretary for Health, Infectious Diseases, U.S. Department of Health and Human Services.
Yesterday, during the International AIDS Conference, I spoke with D...
Various dermatological conditions have been associated with HIV disease since the beginning of the AIDS epidemic. The purple lesions characteristic of Kaposi's sarcoma (KS) became a symbol for this modern plague. Other skin complications -- such as h...